Hyperuricemic nephropathy (HN) is a serious kidney complication of hyperuricemia, yet effective treatments are lacking. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has been implicated in renal tubular injury, but its regulatory mechanisms in HN remain unclear. This study investigated the protective effects of diosmetin (DIOS), a natural flavonoid with antioxidant properties, against monosodium urate (MSU)-induced damage in HK-2 human renal tubular cells. We confirmed that MSU-induced cell death was characteristic of ferroptosis. Through a combination of transcriptomic analysis and network pharmacology, we identified the BNIP3/Nrf2/GPX4 pathway as the primary potential target of DIOS. Molecular docking and subsequent experimental validation demonstrated that DIOS directly interacts with and modulates BNIP3, leading to the activation of Nrf2 and the upregulation of its downstream target, GPX4. This cascade enhanced the cellular antioxidant defense system, effectively suppressing lipid peroxidation and ferroptosis. Our findings reveal a novel mechanism by which DIOS protects against MSU-induced renal tubular injury and highlight the BNIP3/Nrf2/GPX4 axis as a promising therapeutic target for mitigating ferroptosis in HN.